The ARV-825 Diaries
Avoid coadministration of sensitive CYP3A4 substrates with ivosidenib or swap with different therapies. If coadministration is unavoidable, monitor individuals for loss of therapeutic outcome of those medication.Quantifying and addressing losses alongside the continuum of look after individuals residing with HIV infection in sub-Saharan Africa: a s